Compare CSX Corporation (CSX) vs Procter & Gamble Co (PG) Price & Performance

CSX trades at $50.27, down 0.85% on the day, with a neutral technical signal and bullish moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.54 versus $0.518 expected, driven by 10% revenue growth and 17% operating income increase. The company raised 2026 guidance to mid-to-high-single-digit revenue growth and margin expansion. Analyst consensus is bullish with 59% buy ratings and a $52.57 price target, implying 4.6% upside from current levels.

Outlook remains positive due to strong volume growth and operational efficiency, but risks include fuel cost pressures and economic sensitivity. The stock offers value through consistent dividends and earnings momentum, though valuation multiples appear elevated with P/E at 29.23. Investors should monitor execution against raised guidance and industry headwinds.

Procter & Gamble (PG) trades at $145.21, down 0.39% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $84.28 billion in 2025, with net income of $15.97 billion and a strong net margin of 18.44%. Recent earnings have consistently beaten expectations, and a dividend of $1.09 per share is scheduled for payment in August 2026. Analyst consensus is bullish with a price target of $161.20, though valuation multiples like P/E of 22.12 and P/S of 4.08 are at premiums to peers.

PG offers stability with consistent earnings beats and a reliable dividend, but premium valuations and soft demand outlook pose near-term risks. Supply chain improvements and brand partnerships provide growth catalysts, while economic sensitivity and competitive pressures remain headwinds. The stock presents a balanced opportunity for income-focused investors seeking defensive exposure amid market volatility.